Avicanna Inc. reported revenue results for the six months ended June 30, 2022. For the period, the company reported revenue of $2.14 million, representing 101% increase from the same period in the prior year, supported by increased international and licensing revenue and through further progress across the Canadian commercialization efforts.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.37 CAD | +2.78% | -2.63% | +5.71% |
04-19 | Avicanna Raises About $2.1 Million in Non-brokered Private Placement | MT |
04-18 | Avicanna Inc. announced that it has received CAD 2.125584 million in funding | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+5.71% | 25.67M | |
+2.67% | 42.75B | |
+47.70% | 41.61B | |
+12.22% | 41.34B | |
-8.83% | 26.59B | |
+8.30% | 25.49B | |
-22.52% | 18.12B | |
+31.20% | 12.24B | |
-1.48% | 11.76B | |
+9.05% | 11B |
- Stock Market
- Equities
- AVCN Stock
- News Avicanna Inc.
- Avicanna Inc. Reports Revenue Results for the Six Months Ended June 30, 2022